Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. Industriels
  2. Médicament
  3. HAXIFAL (céfaclor)
  • icone plus
  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités
Listen Listen
Add to my selection
  • History
  • Technical informations
Share
Share on
Facebook share - facebook.com - new window
Tweeter share - Partager sur Twitter - twitter.com - new window
LinkedIn share - linkedin.com - new window
Print

HAXIFAL (céfaclor)

Medicine - Posted on Feb 05 2016 - Updated on Jun 12 2019
Active substance (DCI)
  • céfaclor
history (2)
  • 1/20/16

    HAXIFAL (céfaclor)

    Modification du périmètre et du niveau de prise en charge
    icône flèche
  • 6/18/03

    HAXIFAL 250 mg, comprimé effervescent (boîte 10, boîte de 20) HAXIFAL 500 mg, comprimé effervescent (boîte de 20)

    HAXIFAL 250 mg, comprimé effervescent (boîte 10, boîte de 20) HAXIFAL 500 mg, comprimé effervescent (boîte de 20)
    icône flèche
Technical information
ATC code
  • J01DC04
Manufacturer
EREMPHARMA
Presentation

HAXIFAL 500 mg, comprimé effervescent (code CIS : 68995424) 1 tube(s) polypropylène de 10 comprimé(s) - Code CIP : 3400936078895

All our publications
    Bacterial infections Drug therapy Otorhinolaryngologic diseases - miscellaneous Respiratory tract diseases - miscellaneous Urologic diseases - miscellaneous

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
YwDaVTNbcS7T42MS